All The Sex Issue articles
-
NewsStudy looks for markers that predict risk of severe chlamydia infection
A new study has identified markers that may predict whether a chlamydia infection is likely to ascend into the uterus and endometrium. The work could lead to new diagnostics that can predict a woman’s risk of severe infection.
-
NewsPortable spectroscopy enables detection of vaginal microbes
Surface-enhanced Raman spectroscopy can rapidly and noninvasively detect specific bacterial species in vaginal fluid, enabling early identification of microbiome imbalances.
-
NewsBird-to-human jump by trichomonas parasites illuminated in new study
A new study reveals how genetic changes in the parasite responsible for one of the world’s most common sexually transmitted infections may have helped it adapt to human hosts.
-
NewsResearch reveals STIs during pregnancy linked to adverse birth complications
Common sexually transmitted infections during pregnancy have been linked to a higher risk of significant birth complications including preterm birth, stillbirth and babies born smaller than expected.
-
NewsBeetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy
Researchers find that azuki bean beetles, a common pest, produce larger eggs yielding male offspring when infected with Wolbachia bacteria under elevated temperature and carbon dioxide conditions.
-
NewsScientists discover key protein that enables ‘shock & kill’ strategy for HIV latent virus clearance
Researchers have identified a specific gene transcription factor, BRD9, as a potential key to unlocking the mechanisms behind HIV-1 latency.
-
NewsRapid testing for sexually transmitted infections on the horizon
Birmingham spin-out Linear Diagnostics has been awarded £1m funding to finalise the development of a low-cost, accurate, near-patient diagnostic platform that aims to diagnose STIs from a single sample faster than any commercially available alternative.
-
NewsProof of concept for HIV vaccination that deploys germline-targeting
For a preventative HIV-vaccine to work it should induce broadly neutralising antibodies against all the diverse strains of the virus. The first in-human assessment of germline-targeting strategy with a trimer displays positive results.
-
News‘Loop’hole: HIV-1 hijacks human immune cells using circular RNAs
In a groundbreaking discovery, researchers have identified a never-before-seen mechanism that enables the human immunodeficiency type 1 virus (HIV-1) to evade the body’s natural defenses and use it to support its survival and replication.
-
NewsForever chemicals influence cellular immune response to coronavirus
A new study shows that PFAS influence the cellular immune response to coronavirus and also reveals sex-specific differences as to how the immune system reacts to the virus.
-
NewsDiscovery opens up for new ways to treat chlamydia
Researchers have discovered a type of molecule that can kill chlamydia bacteria but spare bacteria that are important for health.
-
News$2.7 million NIH grant to fund first comprehensive syphilis test
With a four-year, $2.7 million grant from NIAID, researchers aim to develop a one-step confirmatory laboratory test that can definitively diagnose active syphilis infection within 10 minutes.
-
NewsGut microbes release cancer-fighting bile acids that block hormone signals
Bacteria naturally present in the human intestine can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study.
-
NewsPotential first new antibiotic for gonorrhoea since the 1990s is effective and safe, finds trial
Gepotidacin could be a new treatment to treat gonorrhoea, protecting against the threat of treatment-resistant gonorrhoea and improving patient treatment experiences, suggests the results of a phase 3 randomised control trial.
-
NewsParasitic infection and treatment linked to cancer-related gene activity in the cervix
New research has revealed that Schistosoma haematobium, a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more pronounced after treatment.
-
NewsNew antibiotic for multidrug resistant superbug triggers suicide mechanism
Researchers have discovered a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea.
-
NewsFAU secures $1.3 million NIH grant for breakthrough in HIV self-test technology
To address the urgent need for a reliable, rapid and affordable self-test for early HIV detection, researchers have been awarded phase-II of a five-year, $1.3 million grant which will support the development of an innovative disposable microchip technology designed for HIV-1 self-testing during the first two weeks post-infection.
-
NewsResearchers develop new DNA test for personalized treatment of bacterial vaginosis
Researchers have developed a simple DNA PCR-based lab test — built on a more detailed genetic analysis of the main group of bacterial organisms that cause bacterial vaginosis — to help clinicians prescribe the right medicine for each patient.
-
NewsProbe into human cervical stem cells shows lactic acid bacteria can prevent cervical cancer
Researchers have revealed the identity and differentiation process of human cervical stem cells in a world first study. The results showed that lactic acid bacteria can inhibit the development of cervical cancer.
-
NewsStudy yields new data on Mpox vaccine effectiveness in people with HIV
A new study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, especially people with HIV, should receive the second dose of the vaccine as recommended.